key: cord-0972570-57b0l32k
authors: Munoz Mendoza, Jair; Alcaide, Maria L.
title: COVID-19 in a Patient with End-Stage Renal Disease on Chronic in-Center Hemodialysis after Evidence of SARS-CoV-2 IgG Antibodies. Reinfection or Inaccuracy of Antibody Testing
date: 2020-09-06
journal: IDCases
DOI: 10.1016/j.idcr.2020.e00943
sha: 2b96c48c67c6cf71b9f48983f69b77c107d8ba79
doc_id: 972570
cord_uid: 57b0l32k

A patient with end-stage renal disease on hemodialysis with a previous positive SARS-CoV-2 IgG antibody was diagnosed with severe COVID-19. Issues regarding reinfection, the potential lack of antibody protection after asymptomatic infection, the possibility of antibody dependent enhancement and careful interpretation of antibody test results are discussed.

The coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has quickly reached pandemic status since the first case was reported in Wuhan, China, and caused over 15 million infections and half a million deaths worldwide. [1] Antibody testing to SARS-CoV-2 either by Enzyme-Linked Immuno-Sorbent Assay (ELISA) or Chemi-Luminescent Immuno Assay (CLIA) are highly sensitive and specific and may indicate prior infection when the clinical suspicious is high. [2] A recent nationwide prevalence study using serological testing, revealed rates as high as 13% (one third of them asymptomatic) in highly hit areas of Spain, [3] and studies in the US showed rates ranging from 1% to 6.9%. [4] Patients with end-stage renal disease (ESRD) on hemodialysis are at high risk of acquiring SARS-CoV-2, and of developing severe COVID-19 and death, [5, 6] but whether positive serological testing conveys protection against future infection in this population is unknown. Herein, we report a case of COVID-19 in a patient with a prior detection of SARS-CoV-2 IgG antibodies and discuss issues concerning re-infection with SARS-CoV-2, the potential lack of antibody protection after J o u r n a l P r e -p r o o f asymptomatic infection, antibody dependent enhancement and caution for careful interpretation of antibody test results.

A 51-year-old African American male with a history of hypertension and ESRD due to acute tubular necrosis, undergoing chronic hemodialysis thrice weekly, presented to the emergency department in a Hospital in Miami (FL) complaining of fever (38.3ºC) and severe dyspnea for two days. Upon arrival he was in severe respiratory distress, with a respiratory rate of 40 breaths/minute, and an oxygen saturation of 40%. He was afebrile, and hemodynamically stable (blood pressure of 134/48 mmHg and heart rate 74 beats/minute). On physical examination, his heart had a regular rate and rhythm, and bilateral basal crackles were heard on the lungs. His Chest X-ray revealed diffuse bilateral alveolar opacities. Complete blood count revealed normal white 

We describe a case of severe COVID-19 in a patient with ESRD undergoing chronic in-center hemodialysis, who had previously tested positive for IgG antibody against SARS-CoV-2. A reinfection with SARS-CoV-2 presenting as a severe COVID-19 disease after an asymptomatic primary infection is the most probable explanation. Although the likelihood of an initial false positive antibody testing is a consideration, it is less likely as the patient was at high risk for SARS-CoV-2 acquisition while living in a city experiencing the first surge of COVID-19 cases, getting in-center dialysis prior to implementation of strict infection control measures, and where patients were already diagnosed with COVID-19.

Reinfections with other common human coronaviruses can occur, [7] while reinfection with SARS-COV-2 in humans is likely to occur, [8] how often would that happen is yet unknown. Some patients have persistent detection of SARS-CoV-2 RNA for over a month, [9] and re-appearance of SARS-CoV-2 in nasopharyngeal secretions after negative RT-PCR was reported in patients recovered from COVID-19 in China, but it was considered false negative results. [10] The potential development of protective immunity after a primary infection in monkeys re-infected with the same identical SARS-CoV-2 strain would suggest that reinfections with SARS-CoV-2 do not occur. [11] However, few cases with recurrent COVID-19 suggesting reinfection with SARS-CoV-2 were recently reported, [8, 12] and recent findings in humans suggests that protective immunity does not occur in all infected individuals, [13] supporting the possibility of reinfection in our patient.

Seroconversion of IgM and IgG antibodies occur the first week after onset of symptoms, seroconversion rates rise until the fourth week and decline thereafter, by the seventh week Ig M is not detected in most cases, whereas IgG persists longer for a period of time yet unknown. [14] Development and duration of antibody response to SARS-CoV-2 infection in patients with ESRD undergoing hemodialysis is lacking, and whether it is similar to individuals in the general population or have a different course such as noted in other chronic conditions is unknown [15, 16] . Although we believe this is a case of re-infection, we cannot rule out with certainty that the first positive serological testing represents a false positive test or cross reactivity with another coronavirus. Common antibody targets such as S and N proteins used in commercially available serological testing have around 30% similarity with other common coronavirus. [18] We can't neither exclude the possibility of recurrence as recently suggested, [19] since we lack data on the strain of the virus. Future longitudinal studies are needed to evaluate potential reinfections, recurrence, and the duration of antibody detection.

In summary, we present a case of an ESRD patient with a positive IgG antibody test against SARS- 

Coronavirus COVID-19 Global Cases

Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States

Presentation and Outcomes of Patients with ESKD and COVID-19

Epidemiology of COVID-19 in an Urban Dialysis Center

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions

Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound

Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19

False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence

Reinfection could not occur in SARS-CoV-2 infected rhesus macaques

A case report of possible novel coronavirus 2019 reinfection

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

Interpreting Diagnostic Tests for SARS-CoV-2

Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective

The Role of Antibody Testing for SARS-CoV-2: Is There One?

Recurrence or Relapse of COVID-19 in Older Patients: A Description of Three Cases